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Abstract
Despite a growing knowledge about the biological diversity of papillomaviruses (PV), only little is known about non-human
PV in general and about PV mice models in particular. We cloned and sequenced the complete genomes of two novel PV
types from the Norway rat (Rattus norvegicus; RnPV2) and the wood mouse (Apodemus sylvaticus; AsPV1) as well as a novel
variant of the recently described MmuPV1 (originally designated as MusPV) from a house mouse (Mus musculus; MmuPV1
variant). In addition, we conducted phylogenetic analyses using a systematically representative set of 79 PV types, including
the novel sequences. As inferred from concatenated amino acid sequences of six proteins, MmuPV1 variant and AsPV1
nested within the Beta+Xi-PV super taxon as members of the Pi-PV. RnPV2 is a member of the Iota-PV that has a distant
phylogenetic position from Pi-PV. The phylogenetic results support a complex scenario of PV diversification driven by
different evolutionary forces including co-divergence with hosts and adaptive radiations to new environments. PV types
particularly isolated from mice and rats are the basis for new animal models, which are valuable to study PV induced tumors
and new treatment options.
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Introduction
Papillomaviruses (PV) are a diverse group of small, non-
enveloped dsDNA viruses. The structurally conserved circular
genome comprises approximately 8,000 bp and is organized in
several, partially overlapping open reading frames (ORF). They
include the major genes that are present in all PV, namely the
early genes E1 and E2 as well as the late genes L1 and L2. Early
proteins are involved in viral replication, life cycle, and regulation
of viral gene expression, while the late proteins assemble the viral
capsid. Besides the major ORF, additional early genes such as E4
and the viral oncogenes E6 and E7 are present in many PV, and
E5 is encoded in, for example, genital Alpha-PV types.
PV infect epithelial tissues of the skin and mucosa at different
regions in humans and various mammals, and most types causing
epidermal proliferative lesions. Genital human PV (HPV) types are
the etiological agent and the major risk factor of anogenital
cancers (e.g., cervical cancer, vulvar cancer, penile cancer etc.) [1].
The viral oncogenes E6 and E7 are responsible for their ability to
interfere with tumor suppressor genes, such as p53 and the
retinoblastoma protein (pRB) family [2,3]. By targeting p53 and
pRB for proteasomal degradation, the viral oncogenes induce
proliferation and transformation [4].
The molecular mechanisms of cutaneotropic HPV types (Beta-
and Gamma-PV) are different compared to genital HPV.
Nevertheless, cutaneotropic HPV types are very likely a cofactor
in the early onset of cutaneous squamous cell carcinoma (SCC)
[5]. The E6 proteins of cutaneotropic HPV types inhibit repair of
UV-induced DNA-damage, induce genomic instability [6,7],
degrade the pro-apoptotic Bak protein [8–10], inhibit the
proapoptocic function of p53 after DNA-damage [10], and
generally inhibit apoptosis.
Traditionally, PV classification is inferred from the nucleotide
sequence comparison of the L1 gene, defining nucleotide (nt)
similarity thresholds for the delimitation of higher taxonomic units
such as ‘type’, ‘species’, and ‘genus’ [11]. Moreover, phylogenetic
analyses of concatenated genes produce well-supported molecular
trees and identify four assemblages at high taxonomic level [12–
14]. Based on those internal members most distantly related, we
will refer to these supertaxa as Alpha+Omikron-PV, Beta+Xi-PV,
Delta+Zeta-PV, and Lambda+Sigma-PV. Only a few isolated
types cannot be assigned to one of these four large groups. The
number of known non-human PV types has increased over the
past few years resulting in 72 PV types, isolated from 36
mammalian and six sauropsid species [11]. However, knowledge
about animal PV diversity is still poor by comparison to more than
150 known HPV types and only a few PV types have been
described from more than 5,000 mammalian species, potential
serving as hosts. Rodents belong to the better sampled mammal
groups with respect to the presence of PV, and six types are
presently known [15–22]. The majority of rodent-infecting PV
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types constitute the Pi-PV, while a single member each is known
from the distantly related Iota- and Sigma-PV.
So far, different animal models have been used to examine PV
induced tumors in natural occurring lesions of cattle, horse, dog,
rabbit, and the multimammate rat [5]. These models are
suboptimal because of the size of the animals and/or the lack of
commercially available biochemical, biological, and immunolog-
ical reagents. Thus, a non-transgenic mouse model, with naturally
infectious PV types, is an ideal model system to examine PV
induced diseases. Recently, a novel PV type MmuPV1 (originally
designated MusPV) from a laboratory mouse (Mus musculus) has
been isolated that naturally induce papilloma of the skin [23,24].
Such reports are promising for the development of an effective
animal model, and we here present and characterize the complete
genomes of a new variant of MmuPV1 also isolated from a house
mouse (MmuPV1 variant) as well as two novel PV types from a free
ranging Norway rat (Rattus norvegicus, RnPV2), and a wood mouse
(Apodemus sylvaticus, AsPV1). Rodent PV, isolated from rats and
mice as classical laboratory animals, have great research impor-
tance, and we aim at contributing to an improved knowledge
particularly of those organisms.
Results
Genome Organizations
PV associated benign or malignant tumors were not observed in
the animals under investigation. We have isolated and cloned two
novel PV types and one novel variant from three different rodent
species. RnPV2 (HQ625441) was isolated from a rectal smear of
Rattus norvegicus. RnPV2 DNA was additionally detected by PCR in
hair follicles from the face of the same animal. Cutaneotropic
AsPV1 (HQ625440) and MmuPV1 variant (HQ625439) were
isolated from normal ear skin tissue of Apodemus sylvaticus and Mus
musculus, respectively. The genomes of RnPV2, MmuPV1 variant,
and AsPV1 consisted of 7,724 bp, 7,523 bp, and 7,589 bp,
respectively (Fig. 1).
As inferred from protein prediction software programs and
sequence evaluation in a comparative alignment, seven potential
ORF coding for five early proteins (E1, E2, E4, E6 and E7) and
two late proteins (L1 and L2) were identified, respectively (Fig. 1).
The putative E4 ORF was characterized by proline codon-rich
stretches, nested within the E2 ORF, and did not have a typical
start codon (Table S1). Polyadenylation sites for early transcripts
were identified in MmuPV1 variant at nt 4466 to 4471, in AsPV1
at nt 4511 to 4516, and RnPV2 at nt 4589 to 4594.
Polyadenylation sites for late transcripts were only present in
MmuPV1 variant and AsPV1 at nt positions 156 to 161 and 196
to 201, respectively (Fig. 1).
The deduced proteins of the new PV types harbored common
amino acid (aa) motifs (Table S2), which were also present in other
PV. They included two zinc finger motifs (C-X2-C-X29-C-X2-C)
present in E6 and one zinc finger motif present in E7. Moreover,
an ATP/GTP binding site (G-X4-GKS) was located within the
SF3 helicase domain of E1. The E6 gene of MmuPV1 (both type
and variant) had a potential pRB binding motif (L-X-C-X-E; aa
positions 66 to 70), which was absent in other rodent PV. Another
potential pRB binding motif was present in the N-terminal part of
the RnPV2 E7 protein (aa positions 19 to 23). The E7 protein of
MmuPV1 contained a potential PDZ binding domain (X-S/T-X-
L/V; aa position 102 to 105) at the C-terminus, which was absent
in other rodent PV types with the exception of MmPV. However,
a stretch of seven aa between this putative motif and the end of the
protein occurred in MmuPV1, while the PDZ binding motif of
MmPV1 E7 was located at the ultimate C-terminus.
The L1 sequence of RnPV2 showed the highest nucleotide
sequence similarity to MnPV1 (72% similarity), of AsPV1 to
RnPV1 (75% similarity), and of MmuPV1 variant to MmuPV1
(99% similarity). A detailed comparison between the MmuPV1
type and the variant is shown in Table 1. All amino acids
exchanges, which were not very likely altering the characteristics
and charge of the protein, are indicated. Two insertions were
present in the MmuPV1 variant of the E4 and the E2 gene
resulting in one additional aa within each protein. Both insertions
did not influence the following aa of the viral proteins (Table 1).
Putative Transcription Factor Binding Sites (TFBS)
TFBS prediction identified a number of potential cis-regulatory
elements in the upstream regulatory region (URR) of rodent PV.
The URR sequences of rodent PV are comprised of a series of
TFBS such as AP1, NF1, SP1, TEF1 and OCT1, which have been
shown to be relevant in regulation of genital Alpha-HPV and
cutaneous Beta-HPV gene expression (Fig. S1). Moreover, we
identified potential TFBS, which have yet not been studied in
relation to PV (Table S3). As in Alpha- and Beta-PV, the rodent
PV URR was divided into a proximal and a distal enhancer
element. The presence of cis-acting sequences in the proximal
enhancer element was especially conserved, whereas their
positions varied between different PV genera. In Pi- and Iota-
PV, this region contained two E2 binding sites (BS), of which the
proximal E2 BS was located directly upstream of a SP1 BS and
downstream of a TFIID BS (TATA box binding protein). One
potential E1 BS was always located between the two binding sites
of E2. The proximal enhancer of the Sigma-PV EdPV1 was
lacking the second E2 BS. In Pi-PV, the E2 BS in the proximal
enhancer were located approximately 50 and 130 nt upstream of
the transcription starting site. In contrast, the corresponding E2
BS of Iota-PV was located 65 and 115 nt upstream of the
transcription start. Between the second E2 BS and the potential E1
BS of Iota-PV, a NF1 BS was situated 95 nt upstream of the
transcription start. This motif was not present in Pi-PV.
The presence of cis-acting sequences in the distal enhancer
element was only weakly conserved, even within the same PV
genus. At least in most of the Pi-PV, a potential NF1 BS seemed to
be conserved 265 to 260 nt upstream of the transcription start,
whereas this motif was not present in Iota-PV. In Pi-PV, this NF1
BS was accompanied by one to two E2 BS, which were located
upstream and downstream of the NF1 BS. They were always
localized 210 and 290 to 310 nt upstream of the transcription
start, respectively. In the distal enhancer element of Iota-PV, two
E2 BS seemed to be conserved. They were located in close
proximity to each other at 280 to 290 and 290 to 315 nt upstream
of the transcription start. The presence of other potential TFBS
seemed largely not to be conserved, even within the same PV
genus and appeared to be randomly distributed.
Phylogenetic Analysis
The alignment consisted of 3,720 aa positions and 2,556 (69%)
parsimony-informative sites (32.4 per terminal taxon; number of
RAxML distinct alignment patterns: 3,555). In the best-scoring
ML-tree based on concatenated E6–E7-E1–E2-L2–L1 aa se-
quences, mammalian PV were monophyletic (100 LBS) and
segregated into the four supertaxa Alpha+Omikron-PV (96 LBS),
Beta+Xi-PV (90 LBS), Delta+Zeta-PV (86 LBS), and Lamb-
da+Mu-PV (92 LBS; Fig. 2). Rodent PV did not constitute
a monophyletic group and were instead found at three different
phylogenetic positions in the molecular tree: (i) Pi-PV (100 LBS,
including the novel AsPV1 and MmuPV1 variant) within the
Beta+Xi-PV, (ii) Sigma-PV (only EdPV1) within the Lambda+Mu-
Novel Rodent Papillomaviruses
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PV, and (iii) Iota-PV (100 LBS, including MnPV1 and the novel
RnPV2) of uncertain phylogenetic position at the base of the tree.
The closest relatives of Pi-PV were Gamma-PV (88 LBS) found on
primates, while EdPV1 was the closest relative of HPV41 (100
LBS); the sister group of Iota-PV could not be determined reliably.
With respect to the novel PV sequences, contradictory tree
topologies between single genes as well as gene combinations were
not observed (data not shown).
Discussion
Despite the efforts that have been made to clone and to
characterize novel PV types from different animal host species,
knowledge about non-human PV diversity is generally sparse. The
only two PV types naturally infecting common laboratory animals
have been identified in the Norway rat (RnPV1) [22] and NMRI-
Foxn1nu/Foxn1nu (nude) mice (MusPV) [23,24]. In our study, we
present the complete genome sequences of two novel PV types and
one variant, naturally infecting free ranging individuals of the
Norway rat (RnPV2), the wood mouse (AsPV1), and the house
mouse (MmuPV1 variant).
So far, several animal models with naturally infecting PV exist
and have been used to examine molecular mechanisms of PV
(including large domestic species such as rabbits, dogs, cattle, and
horses). Mastomys coucha is the best examined laboratory animal
model with naturally infecting PV types. MnPV1 and McPV2 are
associated with benign and rarely malignant transformation of skin
and mucosa, and this model is currently used to study PV-induced
carcinogenesis [18,25]. However, the complete genome of the host
Mastomys coucha has not been sequenced yet and additionally
immunological tools, i.e. antibodies are lacking. Thus, biological
and immunological mechanisms of carcinogenesis are very difficult
to examine. Recently, a novel PV type (MmuPV1) has been cloned
from laboratory mice [23,24]. MmuPV1 induces papilloma at the
nose and mouth of nude mice NMRI-Foxn Inu/Foxn Inu, which
are transmissible to other immunocompetent laboratory mice.
Based on the high sequence similarity it is very likely that the novel
MmuPV1 variant isolated in our study will have the same
properties, which are warranted to examine in further studies.
Papillomavirus diversity results from different evolutionary
mechanisms [14,26–28] such as co-divergence with the hosts,
lateral transfer (i.e., host switch), and adaptive radiation establish-
ing new ecological niches. The existence of three, only distantly
related rodent PV lineages (namely Iota-, Pi-, and Sigma-PV)
rejects the hypothesis of co-divergence between the viruses and
their hosts at a global scale [22,28]. Even more strikingly, the two
different PV types each isolated from Rattus norvegicus and Mastomys
coucha, respectively, do not constitute monophyletic groups.
Figure 1. Genome organization of RnPV2, MmuPV1 variant, and AsPV1. Boxes indicating PV genes are drawn to scale and genes are drawn
in three lines representing three putative open reading frames relative to nt position zero at the beginning of the upstream regulatory region. The
polyadenylation sites are indicated with triangles.
doi:10.1371/journal.pone.0047164.g001
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However, a co-phylogenetic structure can be stated at least
between Muridae [29] and Pi-PV, as far as the weakly resolved
nodes in both viral and host trees allow for this observation. Based
on robust phylogenetic inference determination and quantification
of the different evolutionary forces that have led to PV diversity
remain a major future task.
The viral tropism is rather conserved among the different PV
lineages, although evolutionary shifts of this trait have taken place,
for example, within the Alpha-PV [30]. The majority of types in
this group are mucosotropic, with the exception of the cutaneo-
tropic species Alpha-2 PV and Alpha-4 PV. Character polarity is
not distinct among rodent PV, but it is noteworthy to state that
each group, Iota- and Pi-PV, does include both cutaneotropic and
mucosotropic types. Neither cutaneotropic nor mucosotropic types
constitute monophyletic groups within Pi-PV (the lineage with the
most rodent PV types known), which requires more than one
evolutionary step in terms of this character trait to explain. We
have isolated RnPV2 genome from a rectal smear and have
detected RnPV2 DNA additionally in hair follicles from the face of
the same individual. Thus, at present it is unknown whether
lesions are induced by RnPV2, and the tropism is also unclear.
Therefore studies examining the potential role of the new rodent
PV during the development of skin or anogenital cancer are
warranted.
The presence of TFBS such as AP1, NF1 [31], SP1 [32], TEF1
and OCT1 [33] have been shown to be relevant in regulation of
Alpha-HPV gene expression. Potential binding sites of further
cellular transcription factors within the PV URR have not been
experimentally studied in relation to PV. We show here that the
presence of potential TFBS, and their relative position to the
transcriptional start site, is very similar in rodent PV belonging to
the same genus, but different in rodent PV belonging to different
genera. Genital Alpha- and cutaneous Beta-PV also exhibit
conserved URR organizations among PV types belonging to the
same genus. But the positions of specific TFBS within the URR
are different comparing PV types from two different genera
[34,35]. Differences in URR organizations of genital Alpha- and
cutaneous Beta-PV largely coincide with a different tissue tropism
of the respective PV. This may reflect adaptations of the viral
regulation to different environments. Pi- and Iota-PV also
represent different PV genera with partially identical host range
among rodents. The only data about tissue tropism of rodent PV
are available of MnPV1 and McPV2 isolated from skin tumors
and genital tumors of Mastomys coucha [18,25]. From most rodent
species, only one PV type has been isolated indicating the lack of
knowledge about tissue tropism of EdPV, MmiPV, MaPV1, and
RnPV1 [15,20–22]. Therefore, it is not clear whether each of the
different organizations of the URR in the respective rodent PV is
reflected by a different tropism, which might be a general feature
for all PV.
Putative E6 and E7 proteins of MmuPV1 variant and RnPV2
display aa motifs that have been shown to be responsible for
transforming properties of high-risk HPV types. RnPV2 E7 has
a potential pRB binding motif in its N-terminal domain that has
been first described and exists in the E7 protein of high-risk HPV
types [2]. E6 of MmuPV1 and MmuPV1 variant contains
a potential pRB binding motif, which is usually present in E7
proteins. Moreover, E7 of both types contains a C-terminal PDZ
binding motif that is normally a feature of E6 [3]. Interestingly, the
PDZ binding motif in E7 of MmuPV locates at the C-terminus as
MmPV1 E7 from Rhesus macaques, which has been shown to
interact with cell polarity and cell motility [36]. Thus, functional
Table 1. Sequence comparison between MmuPV1 and the novel MmuPV1 variant.
Genes E6 E7 E1 E2 E4 L2 L1
Position of ORF (including stop codon)
MmuPV1 (7510 bp) 610 to 1032 1032 to 1364 1351 to 3213 3143 to 4294 3711 to 4028 4354 to 5970 5900 to 7510
MmuPV1 variant (7523 bp) 620 to 1042 1042 to 1374 1361 to 3223 3153 to 4307 3721 to 4041 4367 to 5983 5913 to 7523
Lenght of ORF (including stop codon)
MmuPV1 423 333 1863 1152 318 1617 1611
MmuPV1 variant 423 333 1863 1155 321 1617 1611
Number of amino acids
MmuPV1 140 110 620 383 105 538 536
MmuPV1 variant 140 110 620 384 106 538 536
Sequence identities of nucleotides (amino acids)
97% (98%) 98% (98%) 99% (100%) 99% (99%) 92% (93%) 99% (100%) 99% (99%)
Positions of amino acid insertion of MmuPV1 variant
250 G 62 D
Position of amino acid exchanges (MmuPV1/MmuPV1 variant)
43 I/L 27 L/P 47 N/S 249 V/Y 48 P/Q 252 V/E 16 A/V
44 Q/H 94 V/L 299 M/V 285/286 N/S 59 E/D 332 S/G 40 L/P
139 L/S 501 M/V 286/287 S/I 60 Y/T 62 F/S
358/359Y/H 83/84 Q/R 77 F/Y
86/87 R/K 81 I/L
95/96 T/A
96/97A/S
ORF, open reading frame; bp, base pairs.
doi:10.1371/journal.pone.0047164.t001
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Figure 2. Maximum Likelihood (ML) tree of papillomaviruses (PV). ML tree comprising a representative set of 79 types including our two
novel types (AsPV1, RnPV2) and one variant (MmuPV1 variant), as inferred from predicted E6, E7, E1, E2, L2, and L1 aa sequence analysis (3,720 aa
positions, of which 69% were parsimony-informative). Generic PV clades [11] are indicated by Greek lettering. Supertaxa are colored red
(Alpha+Omikron-PV), green (Beta+Xi-PV), blue (Delta+Zeta-PV), and ocher (Lamda+Mu-PV), respectively. Branch lengths are drawn to scale, with the
scale bar indicating the number of nt substitutions per site. Numbers on branches are bootstrap support values under the ML criterion; values under
50 are not shown. The novel PV types and variant of our present study are highlighted by arrows. According to the common PV-nomenclature our
novel variant of Mus musculus is referred to MmuPV1 variant.
doi:10.1371/journal.pone.0047164.g002
Novel Rodent Papillomaviruses
PLOS ONE | www.plosone.org 5 October 2012 | Volume 7 | Issue 10 | e47164
studies will clarify these alternative binding motifs of MmuPV1
and the novel variant.
In our present study, we have isolated the whole genome of two
novel wild living rodent PV types and a variant of a house mouse.
Moreover, we have characterized the sequences of the novel PV
types and have performed phylogenetic analysis. This information
will be helpful to better understand the evolutionary processes and
can serve as a basis to establish powerful animal models with
laboratory mice or rats. The animal models will be valuable to
study molecular mechanisms of PV induced lesions, their in-
teraction with the immune system and novel therapeutic
treatments.
Materials and Methods
Ethics Statement
Animal ethics obtained for the work were not required because
the animals were either from a pest controller (Rattus norvegicus,
Mus musculus) or cooperation partner from forestry institutions
(Apodemus sylvaticus), which caught and sacrificed the animals
during their official duties. The rodents were used with permission
of the pest-control agencies or forestry agencies and institutions
(Deutscher Scha¨dlingsbeka¨mpfer-Verband e.V., Landesverband
Berlin/Brandenburg e.V., Berlin, Germany; Forstliche Versuchs-
und Forschungsanstalt Baden-Wu¨rttemberg, Freiburg, Germany).
No experiments with live animals were performed. The rodents
were killed by the third parties either by means of spring-loaded
mouse traps or rodenticides. Trapping of the animals was
conducted in the framework of monitoring activities for a hanta-
virus outbreak and was coordinated by the Friedrich-Loeffler-
Institut, the Federal Research Institute for Animal Health. The
responsible governmental bodies are the Senat von Berlin and the
Regierungspra¨sidium Baden-Wu¨rttemberg, Germany. The ani-
mals were handled according to the national and European
legislation, namely the EU council directive 86/609/EEC for the
protection of animals.
DNA Isolation and Cloning
All samples (Table S1) were collected under sterile conditions.
They included genital rectal smears of a Norway rat (Rattus
norvegicus; female, adult, field sample: Berlin, Germany); 10–15
eyebrow hair bulbs from the same animal; normal skin from the
ear of a house mouse (Mus musculus; female, adult, field sample:
Berlin, Germany) and a wood mouse (Apodemus sylvaticus; female
adult, field sample: Baden-Wu¨rttemberg, Germany). Genomic
DNA was isolated as previously described [37] and was stored
at 220uC until further analysis.
Rolling Circle Amplification (RCA) was performed to amplify
episomal PV DNA as described previously [38]. RCA products
were used as templates to generate DNA fragments of approxi-
mately 450 bp by PCR with the degenerated FA-primers for a L1-
fragment: [39,40] and CP-primers for an E1-fragment: [41]. The
DNA amplicons were separated by electrophoresis, purified, and
sequenced. PCR products were cloned into the PCR-TOPO 2.1
vector (Invitrogen; Carlsbad, CA, USA), accordingly to manu-
facturer’s instructions. The L1 gene was used to design novel type-
specific primers to amplify the complete genome. Primer
sequences in 59R39 orientation used for the respective PV types
were RnPV2-F: AAG GCA TTT GCA TTT GGA TC; RnPV2-R:
CGT AAG GGG CGG GTA CTA TC; AsPV1-F: ATT GGT
GTC TGT CTC TGC TT; AsPV1-R: CTG GCA AGT CCT
ACT TTT GT; MmuPV1-F: TGG GTT TCT TAA AGG TCG
TG; MmuPV1-R: ACG CCT GGG CAT TCT TAT TG. To
amplify the whole genomic regions of the respective PV types,
a final concentration of 0.5 mM primer pairs, 0.2 mM dNTPs,
0.5 mM MgCl2, 5 U LongAmpPol polymerase (NEB; Frankfurt/
Main, Germany), and buffer containing 1.5 mM MgCl2 was used.
After an initial denaturation step at 94uC for 2 min, 35 cycles of
94uC for 10 sec, 60uC for 30 sec, and 68uC for 6 min were carried
out, and the PCR was completed by a final extension step at 68uC
for 10 min. Resulting amplicons of approximately 7.5 kb were
cloned into the PCR-TOPO 2.1 vector. The complete genomes
were sequenced by a primer walking strategy (GLC Genomics;
Berlin Germany). New PV-types were designated RnPV2,
MmuPV1 variant, and AsPV1. All novel PV types are available
upon request (IN).
Protein Prediction
ORF were predicted using ‘ORFinder’ (http://www.ncbi.nlm.
nih.gov/gorf/gorf.html). They were confirmed by manual align-
ment of nucleotide and protein sequences to homologous regions
of most similar PV types using the ‘Se-Al’ program (v2.0a72;
http://tree.bio.ed.ac.uk/software/seal/). Primary sequence anal-
ysis of the predicted proteins was performed with ‘ProtParam’ [42]
and ‘Prosite’ (www.expasy.ch/prosite.html). TFBS were predicted
with ‘Cister’ (http://zlab.bu.edu/˜mfrith/cister.shtml) and
‘MATCH’ (www.generegulation.com/cgi-bin/pup/programs/
match/bin/match.cgi), as previously described [38].
Phylogenetic Analyses
The taxon sample for phylogenetic analyses was representative
for the currently known PV diversity and comprised 79 complete
sequences including the three novel PV sequences. An aa
alignment of the proteins E6–E7-E1–E2-L2-L1 was concatenated
using ‘MAFFT’ v6.523 [43]; http://align.bmr.kyushu-u.ac.jp/
mafft/software/). The data matrix is available upon request (IN).
Phylogenetic analyses were run using distinct models/data
partitions (i.e., six for each gene), with individual per partition
branch length optimization. To explore possible topological
incongruence, concatenated (all six proteins as well as E1–E2
and L2-L1 gene combinations) and separate analyses of single
genes were performed. Maximum likelihood-based analyses were
conducted using the PTHREADS version of ‘RAxML’ VII
(http://www.phylo.org/portal/Home.do) and applying the
rtREV+G substitution model, as previously described [14].
Note
The following GenBank/EMBL/DDBJ accession numbers are
reported in this paper: RnPV2 (HQ625441), MmuPV1 variant
(HQ625439) and AsPV1 (HQ625440).
Supporting Information
Figure S1 Potential binding partners of the upstream
regulatory regions from rodent PV types. Predictions of
several transcription factor binding sites (TFBS) (e.g. binding sites
of viral E1 and E2, TFBS), which have been shown to be involved
in transcriptional regulation of PV are drawn to scale. Asterisks
indicate that the respective binding site is degenerated at one nt
position.
(EPS)
Table S1 Primary sequence analysis of the putative
genes from MmuPV1 variant, AsPV1, and RnPV2,
respectively.
(DOC)
Table S2 Potential functional elements of the putative
proteins from the novel PV types.
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(DOC)
Table S3 Predicted transcription factor binding sites
and other regulatory elements in the rodent PV gen-
omes.
(DOC)
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